2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Bone Neoplasms in 14 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
Excerpt | Relevance | Reference |
---|---|---|
"Diallyl trisulfide (DATS) is a natural organosulfur compound isolated from garlic, and has been reported to possess anticancer activities." | 5.43 | Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway. ( Li, J; Li, K; Li, X; Sun, N; Tian, J; Wang, H, 2016) |
"Osteosarcoma is a primary bone tumor that mainly occurs in children and adolescents." | 1.72 | AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway. ( Liu, C; Shi, J; Wang, X; Wen, K; Zheng, J, 2022) |
"Diallyl trisulfide (DATS) is a natural organosulfur compound isolated from garlic, and has been reported to possess anticancer activities." | 1.43 | Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway. ( Li, J; Li, K; Li, X; Sun, N; Tian, J; Wang, H, 2016) |
"Osteosarcoma is a common malignant bone tumor." | 1.38 | Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling. ( Li, Y; Liu, C; Wang, K; Zhuang, Y, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Zheng, J | 1 |
Liu, C | 2 |
Shi, J | 1 |
Wen, K | 1 |
Wang, X | 1 |
Zhao, J | 2 |
Yan, Y | 1 |
Zhen, S | 1 |
Yu, L | 1 |
Ding, J | 1 |
Tang, Q | 1 |
Liu, L | 1 |
Zhu, H | 1 |
Xie, M | 1 |
Shats, I | 1 |
Gatza, ML | 1 |
Liu, B | 1 |
Angus, SP | 1 |
You, L | 1 |
Nevins, JR | 1 |
Long, XH | 2 |
Zhong, ZH | 1 |
Peng, AF | 2 |
Zhu, LB | 2 |
Wang, H | 2 |
Zhang, GM | 1 |
Liu, ZL | 2 |
Zhou, Y | 1 |
Wang, TF | 1 |
Gao, S | 1 |
Zhou, RP | 1 |
Jin, D | 1 |
Yang, JP | 1 |
Hu, JH | 1 |
Wang, LN | 1 |
Zuo, JL | 1 |
Sun, N | 1 |
Li, X | 1 |
Li, K | 1 |
Tian, J | 1 |
Li, J | 1 |
Yamamoto, T | 1 |
Ohno, T | 1 |
Wakahara, K | 1 |
Nagano, A | 1 |
Kawai, G | 1 |
Saitou, M | 1 |
Takigami, I | 1 |
Matsuhashi, A | 1 |
Yamada, K | 1 |
Shimizu, K | 1 |
Harisi, R | 1 |
Kenessey, I | 1 |
Olah, JN | 1 |
Timar, F | 1 |
Babo, I | 1 |
Pogany, G | 1 |
Paku, S | 1 |
Jeney, A | 1 |
Wang, K | 1 |
Zhuang, Y | 1 |
Li, Y | 1 |
Gong, C | 1 |
Liao, H | 1 |
Wang, J | 1 |
Lin, Y | 1 |
Qi, J | 1 |
Qin, L | 1 |
Tian, LQ | 1 |
Guo, FJ | 1 |
Zhao, G | 1 |
Cai, C | 1 |
Yang, T | 1 |
Qiu, X | 1 |
Liao, B | 1 |
Li, W | 1 |
Ji, Z | 1 |
Zhao, H | 1 |
Guo, M | 1 |
Ma, Q | 1 |
Xiao, C | 1 |
Fan, Q | 1 |
Ma, B | 1 |
Lekmine, F | 1 |
Sassano, A | 1 |
Uddin, S | 1 |
Smith, J | 1 |
Majchrzak, B | 1 |
Brachmann, SM | 1 |
Hay, N | 1 |
Fish, EN | 1 |
Platanias, LC | 1 |
Lawlor, ER | 1 |
Scheel, C | 1 |
Irving, J | 1 |
Sorensen, PH | 1 |
14 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Bone Neoplasms
Article | Year |
---|---|
AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Computational Biolog | 2022 |
LY294002 alleviates bone cancer pain by reducing mitochondrial dysfunction and the inflammatory response.
Topics: Animals; Bone Neoplasms; Cancer Pain; Disabled Persons; Humans; Mitochondria; Motor Disorders; Neura | 2023 |
FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Bone Neoplasms; Breast Neoplasms; Cell Proliferatio | 2013 |
LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferatio | 2014 |
LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Down-Regulation; Enz | 2015 |
MCP-1 stimulates spinal microglia via PI3K/Akt pathway in bone cancer pain.
Topics: Animals; Bone Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Chemokine CCL2; Chromones; Enz | 2015 |
Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway.
Topics: Acetylcysteine; Allyl Compounds; Antineoplastic Agents; Antioxidants; Apoptosis; Bone Neoplasms; Cel | 2016 |
Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Butadienes; Cell | 2009 |
Differential inhibition of single and cluster type tumor cell migration.
Topics: Adolescent; Bone Neoplasms; Cell Culture Techniques; Cell Movement; Cell Proliferation; Chromones; D | 2009 |
Inhibition of c-Met activation sensitizes osteosarcoma cells to cisplatin via suppression of the PI3K-Akt signaling.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Chromones; Cisplatin; Enzyme | 2012 |
LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity.
Topics: Apoptosis; Bone Neoplasms; Caspase 3; Caspase 9; Cell Line, Tumor; Chromones; Down-Regulation; Enzym | 2012 |
MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
Topics: 3' Untranslated Regions; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tu | 2013 |
Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein.
Topics: Bone Neoplasms; Cell Line, Tumor; Chromones; Enzyme Activation; Enzyme Inhibitors; Humans; Interfero | 2004 |
Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors.
Topics: Artificial Gene Fusion; Bone Neoplasms; Butadienes; Cell Adhesion; Cell Division; Chromones; DNA-Bin | 2002 |